1-4 of 4
Haiyan Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: MALAT1 is Associated with Poor Response to Oxaliplatin-based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2

Peilong Li, Xin Zhang, Haiyan Wang, Lili Wang, Tong Liu, Lutao Du, Yongmei Yang, Chuanxin Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (2): 451.
https://doi.org/10.1158/1535-7163.MCT-20-1028
Published: 05 February 2021
View article titled, Correction: MALAT1 is Associated with Poor Response to Oxaliplatin-based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
Open the PDF for Correction: MALAT1 is Associated with Poor Response to Oxaliplatin-based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2 in another window
Journal Articles

MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2

Peilong Li, Xin Zhang, Haiyan Wang, Lili Wang, Tong Liu, Lutao Du, Yongmei Yang, Chuanxin Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (4): 739–751.
https://doi.org/10.1158/1535-7163.MCT-16-0591
Published: 02 April 2017
View article titled, MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
Open the PDF for MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2 in another window
Includes: Supplementary data
Journal Articles

Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model

Eva Tonsing-Carter, Barbara J. Bailey, M. Reza Saadatzadeh, Jixin Ding, Haiyan Wang, Anthony L. Sinn, Kacie M. Peterman, Tiaishia K. Spragins, Jayne M. Silver, Alyssa A. Sprouse, Taxiarchis M. Georgiadis, T. Zachary Gunter, Eric C. Long, Robert E. Minto, Christophe C. Marchal, Christopher N. Batuello, Ahmad R. Safa, Helmut Hanenberg, Paul R. Territo, George E. Sandusky, Lindsey D. Mayo, Christine M. Eischen, Harlan E. Shannon, Karen E. Pollok
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12): 2850–2863.
https://doi.org/10.1158/1535-7163.MCT-15-0237
Published: 06 December 2015
View article titled, Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
Open the PDF for Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model in another window
Includes: Supplementary data
Journal Articles

Abstract B37: Proteomic and metabolomic analyses of glioblastoma using mass spectrometry.

Soo Jung Ha, Gordon Showalter, Jenna Rickus, Shanbao Cai, Haiyan Wang, Wei Michael Liu, Jann N. Sarkaria, John Springer, Jiri Adamec, Karen E. Pollok, Kari L. Clase
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B37.
https://doi.org/10.1158/1535-7163.TARG-13-B37
Published: 01 November 2013
View article titled, Abstract B37: Proteomic and metabolomic analyses of glioblastoma using mass spectrometry.